Literature DB >> 33773888

Successful dupilumab treatment for ichthyotic and atopic features of Netherton syndrome.

Chiaki Murase1, Takuya Takeichi1, Tomoki Taki1, Takenori Yoshikawa1, Akiko Suzuki2, Tomoo Ogi3, Yasushi Suga4, Masashi Akiyama5.   

Abstract

Entities:  

Year:  2021        PMID： 33773888     DOI： 10.1016/j.jdermsci.2021.03.003

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN： 0923-1811            Impact factor:   4.563


× No keyword cloud information.
  3 in total

Review 1.  New developments in the molecular treatment of ichthyosis: review of the literature.

Authors:  M D W Joosten; J M K Clabbers; N Jonca; J Mazereeuw-Hautier; A H Gostyński
Journal:  Orphanet J Rare Dis       Date:  2022-07-15       Impact factor: 4.303

2.  Outcomes of Systemic Treatment in Children and Adults With Netherton Syndrome: A Systematic Review.

Authors:  Anouk E M Nouwen; Renske Schappin; N Tan Nguyen; Aviël Ragamin; Anette Bygum; Christine Bodemer; Virgil A S H Dalm; Suzanne G M A Pasmans
Journal:  Front Immunol       Date:  2022-03-30       Impact factor: 8.786

3.  Dupilumab Improves Pruritus in Netherton Syndrome: A Case Study.

Authors:  Yutaka Inaba; Nobuo Kanazawa; Kyoko Muraoka; Azusa Yariyama; Ami Kawaguchi; Kayo Kunimoto; Chikako Kaminaka; Yuki Yamamoto; Kaoru Tsujioka; Akira Yoshida; Teruki Yanagi; Masatoshi Jinnin
Journal:  Children (Basel)       Date:  2022-02-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.